美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

CAR-T

1,262.21

-6.6146-0.52%

漲家數：1

跌家數：2

平家數：- -

市盈率：- -

高：1,290.64

開：1,287.54

低：1,258.39

收：1,268.82

資料載入中...

歐洲製藥公司警告歐盟，關税迫在眉睫，它們將遷往美國

藍鳥生物盤中異動大幅拉昇5.87%

創新藥多點突破，華東醫藥、禮來、諾華多維綻放

医药经济报

吉利德科學4月4日成交額為14.15億美元

吉利德科學盤中異動股價大跌3.00%

諾華製藥盤中異動快速跳水3.04%報108.85美元

吉利德科學4月3日成交額為11.36億美元

吉利德科學：必妥維在中國獲批用於更廣泛的HIV感染者羣體

諾華(NVS.US)“潛在重磅”新藥在中國獲批新適應症

吉利德科學：多地裁員，中國情況未明

吉利德中國回應裁員：正在進一步調整資源，為長效HIV新藥等近期上市的產品做準備

吉利德科學3月31日成交額為9.86億美元

美股抗疫概念股多數下跌，Moderna跌近9%

每日经济新闻

青鳥生物收到非約束性競標，競標價高達 1.105 億美元

BUZZ-受收購要約影響，藍鳥生物股價尾盤大漲 11

藍鳥生物公司公佈截至 12 月 31 日的季度業績 - 收益摘要

吉利德科學3月26日成交額為8.09億美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4578/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T","latestPrice":1262.205,"timestamp":1744137678598,"preClose":1268.8196,"halted":0,"volume":7660393,"delay":0,"changeRate":-0.005213,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-6.614624,"latestTime":"04-08 14:41:18 EDT","open":1287.5441,"high":1290.6422,"low":1258.3945,"amount":786787852.131398,"amplitude":0.025415,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1744142400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.151172,"peRate":26.789048,"turnoverRate":0.002505,"increases":1,"decrements":2,"flats":0,"marketCap":332849235532,"floatMarketCap":315137788660},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1290.6422,"amplitude":0.025415,"preClose":1268.8196,"low":1258.3945,"pbRate":"5.151172","latestPrice":1262.205,"volume":7660427,"delay":0,"open":1287.5441,"prevYearClose":1164.883,"prevWeekClose":1299.4656,"prevMonthClose":1364.0579,"prevQuarterClose":1364.0579,"fiveDayClose":1346.7324,"twentyDayClose":1374.4496,"sixtyDayClose":1166.6005,"secType":"PLATE","market":"US","turnoverRate":0.002505,"peRate":26.789048,"marketCap":332849235532,"floatMarketCap":315137788660,"timestamp":1744137679045,"nameCN":"CAR-T"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":1,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525814022","title":"歐洲製藥公司警告歐盟，關税迫在眉睫，它們將遷往美國","url":"https://stock-news.laohu8.com/highlight/detail?id=2525814022","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525814022?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 23:10","pubTimestamp":1744125003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["01477","IE00BFTCPJ56.SGD","LU1829250122.USD","IE00B4R5TH58.HKD","EURmain","EUO","BK1574","LU0320765992.SGD","LU0070302665.USD","LU2456880835.USD","BK4568","BK1191","LU0109394709.USD","LU0320765489.SGD","IE0002141913.USD","FXE","LU2462157665.USD","LU2236285917.USD","IE00BJJMRZ35.SGD","BK4585","LU0208291251.USD","BK5011","LU0889565916.HKD","LU2417539215.USD","AZN","MEURmain","IE00BJT1NW94.SGD","IE0009355771.USD","IE00B2B36J28.USD","BK4578","BK4007","LU0211331839.USD","BK4588","BK4532","NVS","0P6S.UK"],"gpt_icon":0},{"id":"2525614818","title":"藍鳥生物盤中異動 大幅拉昇5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525614818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525614818?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 21:35","pubTimestamp":1744119349,"startTime":"0","endTime":"0","summary":"北京时间2025年04月08日21时35分，蓝鸟生物股票出现波动，股价急速拉升5.87%。截至发稿，该股报5.05美元/股，成交量3.7406万股，换手率0.38%，振幅2.10%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为1.66%。其相关个股中，60 Degrees Pharmaceuticals, Inc.、Onconetix, Inc.、Cormedix Inc.涨幅较大，Onconetix, Inc.、60 Degrees Pharmaceuticals, Inc.、Naya Biosciences, Inc.较为活跃，换手率分别为820.61%、695.19%、43.40%，振幅较大的相关个股有Onconetix, Inc.、60 Degrees Pharmaceuticals, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为33.61%、27.80%、22.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408213549a6b42cce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408213549a6b42cce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4578","BK4139","BK4556","BLUE"],"gpt_icon":0},{"id":"2525500258","title":"創新藥多點突破，華東醫藥、禮來、諾華多維綻放","url":"https://stock-news.laohu8.com/highlight/detail?id=2525500258","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525500258?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 11:48","pubTimestamp":1744084133,"startTime":"0","endTime":"0","summary":"全球仅3款，华东医药三靶点抗体融合蛋白获批临床4月7日，华东医药发布公告，其控股子公司道尔生物申报的注射用 DR30206 临床试验申请获得批准，联合标准化疗，拟用于晚期或转移性消化道肿瘤患者。礼来乳腺癌1类新药在华申报上市4月8日，CDE官网最新公示，礼来申报的1类新药imlunestrant片上市申请获得受理。本次Imlunestrant于中国申报上市，意味着其临床研发进程将迎来新的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408164835a6b3d5c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408164835a6b3d5c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2357305700.SGD","LU1989771016.USD","LU2237443895.HKD","LU1868836591.USD","LU2361044865.SGD","LU1868836914.USD","LU2324357040.USD","IE00BFTCPJ56.SGD","LU0238689110.USD","BK4516","LU1023059063.AUD","LU1280957306.USD","LU2602419157.SGD","LU1064131342.USD","NVS","LU0689472784.USD","LU2552382058.USD","LU0070302665.USD","LU0385154629.USD","LU0882574139.USD","LU2552382215.SGD","LU2089984988.USD","LU1720051108.HKD","LU0354030438.USD","LU2237443622.USD","SGXZ57979304.SGD","LU1868837300.USD","LU1035775433.USD","LU0114720955.EUR","LU0211331839.USD","SG9999017495.SGD","SGXZ51526630.SGD","SG9999001176.USD","LLY","LU0203202063.USD","LU1917777945.USD","IE00B1BXHZ80.USD","SG9999018857.SGD","LU1093756325.SGD","LU0943347566.SGD","LU2491050154.USD","LU2361045086.USD","LU2106854487.HKD","LU1623119135.USD","IE00BK4W5L77.USD","LU0198837287.USD","BK4578","LU0122379950.USD","SGXZ99366536.SGD","IE00BJJMRZ35.SGD"],"gpt_icon":1},{"id":"2525768890","title":"吉利德科學4月4日成交額為14.15億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525768890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525768890?lang=zh_tw&edition=fundamental","pubTime":"2025-04-05 09:32","pubTimestamp":1743816730,"startTime":"0","endTime":"0","summary":"美东时间2025年4月4日，吉利德科学成交额为14.15亿美元，成交额较昨日增加24.53%，当日成交量为1292.00万股。吉利德科学于2025年4月4日跌4.57%，报107.25美元，该股过去5个交易日跌4.06%，年初至今涨16.93%，过去60日涨19.17%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405093214a44e6390&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405093214a44e6390&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BSNM7G36.USD","BK4550","IE00BKVL7J92.USD","LU0320765992.SGD","LU1066051498.USD","LU1066053197.SGD","LU0889565916.HKD","BK4578","LU1571399168.USD","LU0234570918.USD","BK4566","LU0109394709.USD","LU1430594728.SGD","BK4139","BK4583","BK4568","IE00B3T34201.USD","IE00B7SZLL34.SGD","BK4532","LU2087621335.USD","LU1839511570.USD","BK4588","LU2468319806.SGD","BK4585","LU2089984988.USD","IE0002270589.USD","IE00B19Z3581.USD","GILD","LU0058720904.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","LU1585245621.USD"],"gpt_icon":0},{"id":"2525733954","title":"吉利德科學盤中異動 股價大跌3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525733954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525733954?lang=zh_tw&edition=fundamental","pubTime":"2025-04-05 01:00","pubTimestamp":1743786014,"startTime":"0","endTime":"0","summary":"北京时间2025年04月05日01时00分，吉利德科学股票出现波动，股价急速跳水3.00%。截至发稿，该股报109.02美元/股，成交量625.236万股，换手率0.50%，振幅3.50%。吉利德科学股票所在的制药行业中，整体跌幅为5.07%。吉利德科学公司简介：吉利德科学开发和营销用于治疗威胁生命的传染病的疗法，其投资组合的核心集中在艾滋病毒，乙型和丙型肝炎。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405010014972e9509&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405010014972e9509&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU2468319806.SGD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","BK4532","IE0002270589.USD","LU0320765992.SGD","IE00BZ1G4Q59.USD","LU0058720904.USD","IE00B19Z3B42.SGD","BK4585","LU1430594728.SGD","BK4578","LU0234570918.USD","IE00BSNM7G36.USD","LU0889565916.HKD","LU2087621335.USD","LU0109394709.USD","LU1066051498.USD","LU1585245621.USD","BK4588","IE00BKVL7J92.USD","BK4566","LU1066053197.SGD","IE00B3T34201.USD","BK4550","LU1839511570.USD","BK4568","LU2089984988.USD","LU1571399168.USD","GILD","LU0289739699.SGD","BK4583"],"gpt_icon":0},{"id":"2524786470","title":"諾華製藥盤中異動 快速跳水3.04%報108.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524786470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524786470?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 21:48","pubTimestamp":1743774529,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日21时48分，诺华制药股票出现异动，股价大幅跳水3.04%。截至发稿，该股报108.85美元/股，成交量89.6238万股，换手率0.05%，振幅0.89%。机构评级方面，在所有28家参与评级的机构中，18%的券商给予买入建议，68%的券商给予持有建议，14%的券商给予卖出建议。诺华制药股票所在的制药行业中，整体跌幅为2.98%。诺华制药公司简介：诺华开发和生产创新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040421484994cc0c13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040421484994cc0c13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVS","BK4578","IE00BJT1NW94.SGD","BK4585","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4007","IE0009355771.USD","LU0320765489.SGD","LU0070302665.USD","IE0002141913.USD","BK4588","BK4532","LU0208291251.USD","IE00B2B36J28.USD","LU0211331839.USD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2524634247","title":"吉利德科學4月3日成交額為11.36億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524634247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524634247?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 09:31","pubTimestamp":1743730316,"startTime":"0","endTime":"0","summary":"美东时间2025年4月3日，吉利德科学成交额为11.36亿美元，成交额较昨日增加36.87%，当日成交量为1004.52万股。吉利德科学于2025年4月3日涨0.45%，报112.39美元，该股过去5个交易日涨1.11%，年初至今涨22.53%，过去60日涨24.06%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404093206a44d5083&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404093206a44d5083&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1839511570.USD","LU0109394709.USD","LU0234570918.USD","LU2089984988.USD","GILD","IE00BZ1G4Q59.USD","BK4585","LU1066053197.SGD","IE00B3T34201.USD","LU1571399168.USD","BK4532","LU2468319806.SGD","BK4583","IE00BKVL7J92.USD","LU0058720904.USD","BK4566","BK4139","LU2087621335.USD","LU0889565916.HKD","LU0320765992.SGD","LU1430594728.SGD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","IE0002270589.USD","LU1585245621.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU1066051498.USD","BK4588","BK4550","BK4568","BK4578","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2524401009","title":"吉利德科學：必妥維在中國獲批用於更廣泛的HIV感染者羣體","url":"https://stock-news.laohu8.com/highlight/detail?id=2524401009","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524401009?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 14:14","pubTimestamp":1743660878,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU2087621335.USD","IE00B3T34201.USD","IE00BKVL7J92.USD","IE0002270589.USD","GILD","IE00B19Z3581.USD","BK4588","LU0320765992.SGD","IE00BSNM7G36.USD","LU0058720904.USD","LU1571399168.USD","BK4578","LU0889565916.HKD","BK4566","LU1839511570.USD","BK4532","LU1066051498.USD","LU1066053197.SGD","LU2089984988.USD","BK4550","BK4568","LU0109394709.USD","LU0234570918.USD","LU2468319806.SGD","BK4583","LU1430594728.SGD","BK4585","LU0289739699.SGD","IE00B19Z3B42.SGD","BK4139","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","LU1585245621.USD"],"gpt_icon":0},{"id":"2524495992","title":"諾華(NVS.US)“潛在重磅”新藥在中國獲批新適應症","url":"https://stock-news.laohu8.com/highlight/detail?id=2524495992","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524495992?lang=zh_tw&edition=fundamental","pubTime":"2025-04-02 20:59","pubTimestamp":1743598752,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月2日，诺华宣布盐酸伊普可泮胶囊获得中国国家药品监督管理局批准新适应症，用于治疗成人C3肾小球病以降低蛋白尿。本次是该产品在中国获批的第二项适应症，此前其已经于2024年4月获NMPA批准用于治疗PNH成人患者。C3肾小球病是原发性肾小球肾炎的一种罕见和严重形式，以补体失调为特征。由于目前没有获批疗法，患者具有严重未满足的临床需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1273506.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0070302665.USD","LU0208291251.USD","IE00BJJMRZ35.SGD","BK4578","NVS","BK4532","IE00BJT1NW94.SGD","LU0211331839.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","IE0009355771.USD","IE00B2B36J28.USD","BK4585","BK4007","BK4588","LU0320765489.SGD"],"gpt_icon":0},{"id":"2524119670","title":"吉利德科學：多地裁員，中國情況未明","url":"https://stock-news.laohu8.com/highlight/detail?id=2524119670","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524119670?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 20:55","pubTimestamp":1743512137,"startTime":"0","endTime":"0","summary":"快讯摘要2024 年底至 2025 年 3 月吉利德科学多地裁员，吉利德中国未透露裁员规模，称在为新品上市调整资源。快讯正文【2024 年年底至 2025 年 3 月，吉利德科学多地裁员并将结束子公司工厂运营】2024 年年底至 2025 年 3 月，跨国药企吉利德科学分别在西雅图办事处、加州总部进行裁员，并宣布 2025 年中结束运营其细胞治疗子公司 Kite Pharma 在费城的工厂。日前，吉利德中国同样流出裁员消息。4 月 1 日，吉利德中国方面回应称，公司持续推进长期战略目标，并不断加速临床进展，正在进一步调整资源，为即将推出的产品做准备，但未透露中国区的裁员规模和涉及部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250401210530a6abf6d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250401210530a6abf6d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","LU1571399168.USD","LU1066051498.USD","LU2468319806.SGD","BK4583","BK4588","LU0109394709.USD","LU0289739699.SGD","LU0058720904.USD","LU0320765992.SGD","IE0002270589.USD","IE00B19Z3581.USD","BK4566","BK4578","LU1430594728.SGD","IE00BKVL7J92.USD","LU1839511570.USD","LU2089984988.USD","LU0234570918.USD","BK4585","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","LU1066053197.SGD","BK4550","BK4532","BK4139","LU1585245621.USD","LU2087621335.USD","IE00B3T34201.USD","GILD"],"gpt_icon":0},{"id":"2524190642","title":"吉利德中國回應裁員：正在進一步調整資源，為長效HIV新藥等近期上市的產品做準備","url":"https://stock-news.laohu8.com/highlight/detail?id=2524190642","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524190642?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 19:52","pubTimestamp":1743508352,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4588","BK4578","LU0320765992.SGD","IE00BSNM7G36.USD","BK4568","BK4585","KITE","BK4583","BK4550","LU1430594728.SGD","LU1571399168.USD","BK4532","LU0289739699.SGD","IE00BKVL7J92.USD","IE0002270589.USD","IE00B19Z3581.USD","LU0058720904.USD","GILD","LU1066051498.USD","LU2468319806.SGD","BK4139","IE00B7SZLL34.SGD","LU0109394709.USD","LU0889565916.HKD","LU1839511570.USD","IE00B3T34201.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","LU2087621335.USD","LU1585245621.USD","BK4566","LU0234570918.USD","LU2089984988.USD","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2524186401","title":"吉利德科學3月31日成交額為9.86億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524186401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524186401?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 09:32","pubTimestamp":1743471150,"startTime":"0","endTime":"0","summary":"美东时间2025年3月31日，吉利德科学成交额为9.86亿美元，成交额较昨日增加12.60%，当日成交量为882.88万股。吉利德科学于2025年3月31日涨0.23%，报112.05美元，该股过去5个交易日涨4.97%，年初至今涨22.16%，过去60日涨22.16%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250401093425a449423b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250401093425a449423b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","GILD","BK4550","LU2468319806.SGD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","BK4583","LU0889565916.HKD","LU1839511570.USD","IE00BSNM7G36.USD","BK4139","LU0289739699.SGD","LU2087621335.USD","BK4566","LU2089984988.USD","LU1571399168.USD","LU1585245621.USD","BK4532","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","LU0234570918.USD","IE00B19Z3B42.SGD","LU0109394709.USD","BK4578","LU1430594728.SGD","LU1066051498.USD","IE0002270589.USD","LU0058720904.USD","LU1066053197.SGD","BK4588","IE00B3T34201.USD","BK4568","LU0320765992.SGD"],"gpt_icon":0},{"id":"2524032999","title":"美股抗疫概念股多數下跌，Moderna跌近9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524032999","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524032999?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 05:57","pubTimestamp":1743458261,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月1日，美股抗疫概念股多数下跌，Moderna跌近9%，吉利德科学涨0.23%，诺瓦瓦克斯医药跌超8%，BioNTech跌逾4%，阿斯利康跌0.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504013361481310.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504013361481310.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1066053197.SGD","LU0234570918.USD","LU1066051498.USD","LU2089984988.USD","GILD","LU0109394709.USD","BK4547","LU0320765992.SGD","IE00B19Z3581.USD","LU0058720904.USD","LU1839511570.USD","IE00B3T34201.USD","BK4583","LU0289739699.SGD","BK4585","LU1571399168.USD","BK4588","NVAX","BK4568","IE0002270589.USD","BK4550","LU2468319806.SGD","IE00BSNM7G36.USD","LU1585245621.USD","BK4578","LU2087621335.USD","LU0889565916.HKD","LU1430594728.SGD","BK4532","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","BK4139","IE00B7SZLL34.SGD","BK4566","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2523639510","title":"青鳥生物收到非約束性競標，競標價高達 1.105 億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2523639510","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523639510?lang=zh_tw&edition=fundamental","pubTime":"2025-03-29 05:39","pubTimestamp":1743197945,"startTime":"0","endTime":"0","summary":"路透社3月28日 - 基因治疗生产商蓝鸟生物BLUE.O周五表示，它已收到同行Ayrmid公司提出的不具约束力的报价，最高可达1.105亿美元，其股价在延时交易中上涨了9.8%，报收于4.40美元。根据路透社利用 LSEG 编制的数据计算，细胞疗法开发商 Gamida Cell 的母公司 Ayrmid 提出以每股 4.50 美元的预付款收购蓝鸟，总价约为 4380 万美元。蓝鸟公司表示，其董事会正在与法律和财务顾问协商审查Ayrmid公司的建议，董事会没有改变支持凯雷和SK Capital Partners交易的建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL3T3QB1KY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4135","IE00BGHQF748.EUR","BK4556","CG","BLUE","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4578"],"gpt_icon":0},{"id":"2523366096","title":"BUZZ-受收購要約影響，藍鳥生物股價尾盤大漲 11","url":"https://stock-news.laohu8.com/highlight/detail?id=2523366096","media":"路透中文","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523366096?lang=zh_tw&edition=fundamental","pubTime":"2025-03-29 05:20","pubTimestamp":1743196815,"startTime":"0","endTime":"0","summary":"** BLUE 的股价在周五常规交易结束时上涨了 7.7%，报收于 4.08 美元。根据双方达成的协议，BLUE 将以每小时 3.00 美元的现金和每小时 6.84 美元的一次性或有价值权被私有化。** BLUE表示正在审查Ayrmid的建议，但仍受凯雷/SK交易条款的限制，其董事会没有改变支持合并的建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL3T3QB1K7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLUE","BK4556","BK4139","BK4578"],"gpt_icon":0},{"id":"2522757518","title":"藍鳥生物公司公佈截至 12 月 31 日的季度業績 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2522757518","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522757518?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 14:10","pubTimestamp":1743142202,"startTime":"0","endTime":"0","summary":"蓝鸟生物公司公布截至 12 月 31 日的季度业绩 - 收益摘要蓝鸟生物公司BLUE.OQ公布的截至12月31日的季度调整后每股亏损为2.95美元，高于去年同期的每股收益15.60美元。七位分析师对该季度的平均预期是每股亏损 5.98 美元。华尔街预期为每股亏损 8.25 美元至 3.65 美元。蓝鸟生物公司公布的本季度每股收益为亏损 2.95 美元。该公司一季度亏损2864万美元。本季度蓝鸟生物公司股价下跌了 54.6%。华尔街对蓝鸟生物公司 12 个月目标价的中位数为 8.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL3T3QB0GE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","BK4139","BK4556","BLUE"],"gpt_icon":0},{"id":"2522362772","title":"吉利德科學3月26日成交額為8.09億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522362772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522362772?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 09:37","pubTimestamp":1743039449,"startTime":"0","endTime":"0","summary":"美东时间2025年3月26日，吉利德科学成交额为8.09亿美元，成交额较昨日减少10.86%，当日成交量为739.19万股。吉利德科学于2025年3月26日涨1.28%，报109.27美元，该股过去5个交易日涨1.64%，年初至今涨19.13%，过去60日涨16.56%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250327093739a6a56c59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250327093739a6a56c59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1066053197.SGD","LU0234570918.USD","LU1066051498.USD","LU2089984988.USD","GILD","LU0109394709.USD","LU0320765992.SGD","IE00B19Z3581.USD","LU0058720904.USD","LU1839511570.USD","IE00B3T34201.USD","BK4583","LU0289739699.SGD","BK4585","LU1571399168.USD","BK4588","BK4568","IE0002270589.USD","BK4550","LU2468319806.SGD","IE00BSNM7G36.USD","LU1585245621.USD","BK4578","LU2087621335.USD","LU0889565916.HKD","LU1430594728.SGD","BK4532","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","BK4139","IE00B7SZLL34.SGD","BK4566","IE00BZ1G4Q59.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}]}}